Hydroxy Tipelukast-d6 Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

Hydroxy Tipelukast-d6 has shown to improve symptoms of fatty liver, lobular inflammation hepatocyte hypertrophy and fibrosis in patients with nonalcoholic fatty liver disease (NAFLD) or nonalcoholic steatohepatitis (NASH).

Hydroxy Tipelukast-d6 Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

Hydroxy Tipelukast-d6 Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
J & K SCIENTIFIC LTD.	010-82848833 400-666-7788	jkinfo@jkchemical.com	China	96815	76
BOC Sciences	1-631-485-4226; 16314854226	info@bocsci.com	United States	14055	65
Cato Research Chemicals Inc.	020-81960175	min.he@cato-chem.com	China	1955	55
Shenzhen Polymeri Biochemical Technology Co., Ltd.	+86-400-002-6226 +86-13028896684;	sales@rrkchem.com	China	57423	58
Shanghai isotope chemical co.,ltd	021-021-51600108 13062666369	sales@chinaisotope.com	China	4271	58

1027597-04-1()Verwandte Suche:

---

• Hydroxy Tipelukast-d6
• MN 002
• Hydroxy Tipelukast
• Butanoic acid, 4-[3-[3-[(4-acetyl-3-hydroxy-2-propylphenyl)thio]propoxy]-6-(1-hydroxyethyl)-2-propylphenoxy]-
• 1027597-04-1
• C29H40O7S